Tenderwize
Back to tender search

Open house Arzneimittelrabattverträge Macrogol in Komb. (ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte oder nach Anlage 5 AM-RL G-BA verordnungsfähige Medizinprodukte), ATC A06AD6

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2028 · 657 days left·Open·Supplies·Framework
Structured notice only
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Macrogol in Komb. (ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte oder nach Anlage 5 AM-RL G-BA verordnungsfähige Medizinprodukte), ATC A06AD6

70/100

Opportunity Score

PromisingLow complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

70 / 100

Complexity

20 / 100

Risk factors

No estimated value provided; financial attractiveness cannot be assessed.

Contracts automatically terminate if a competitive rebate contract for the same active ingredient is concluded at natio...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jul 2028
  • Non-exclusive rebate agreements for Macrogol in combination (ATC A06AD65), limited to products prescribable according to Annex 1 or Annex 5 of the AM-RL by G-BA.
  • Contracts are standard, non-negotiable, and open to all qualifying pharmaceutical companies.
Show full summary

Open-house model for non-exclusive pharmaceutical rebate agreements on Macrogol combinations (ATC A06AD65) by AOK Bayern. Eligible pharma companies can join anytime until 2028-06-03, with contracts running from 2026-08-01 to 2028-07-31. No selection or award criteria; any qualified company can participate. No estimated value provided.

Risks

No estimated value provided; financial attractiveness cannot be assessed.

Contracts automatically terminate if a competitive rebate contract for the same active ingredient is concluded at natio...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Must be a pharmaceutical company (pharmazeutischer Unternehmer).

Administrative

  • Submit signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submit signed contract and annex specifying the products.

Requirements may be incomplete.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge Macrogol in Komb. (ausschließlich nach Anlage 1 AM-RL G-BA verordnungsfähige Produkte oder nach Anlage 5 AM-RL G-BA verordnungsfähige Medizinprodukte), ATC A06AD6

Non-exclusive rebate agreements for Macrogol combination products, open to all qualifying pharmaceutical companies. Contracts are identical and non-negotiable.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jul 2026 - Jul 2028

Category

Pharmaceutical products

Deadline

Deadline Jun 03, 2028

Procurement Details

Publication date
14 Jun 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
408607-2026

Documents (2)

Similar tenders